Xenetic Biosciences, Inc.
What this means
- Net loss in 2025Net loss of $2.7M for the year (2024: −$4M).
What to do next
- How to check a US company before you sign a contractguide
- How to read an 8-K: what customers and creditors should checkguide
Guides from the Companies Daily newsroom, picked for what the register shows.
Financials from XBRL
| Calendar-year frame | 2025 | 2024 |
|---|---|---|
| Revenue | $3M | $2.5M |
| Net income (loss) | −$2.7M | −$4M |
| Total assets | $8.4M | $6.9M |
| Total liabilities | $968K | $894K |
| Stockholders’ equity | $7.4M | $6M |
| Cash and equivalents | $7.9M | $6.2M |
From XBRL data the company filed with the SEC (data.sec.gov frames, US GAAP, US dollars). A frame aligns the fiscal year with the calendar year closest to it; this company’s fiscal year ends December 31. Check the annual report for the exact figures and periods.
- Name as filed
- Xenetic Biosciences, Inc.
Formerly: General Sales & Leasing, Inc. - CIK
- 0001534525
- Tickers
- XBIO
- Kind of filer
- SEC-reporting company
Non-accelerated filer; Smaller reporting company - Status
- Filing with the SEC
- State of incorporation
- Nevada
- Business address
- Framingham, Massachusetts
- Industry (SIC)
- 2834 · Pharmaceutical preparations
Industry: D · Manufacturing → - Fiscal year ends
- December 31
- Last annual report
- 10-K for the period ended Dec 31, 2025
- Last quarterly report
- 10-Q for the quarter ended Sep 30, 2026
- Bankruptcy reported
- Not in our data
- Last edition event
- Nov 13, 2026
Filing history
Newest first: the filings we classify (8-K items, late filing notices, delistings, deregistration, IPO registrations, Schedule 13D, Form D, annual and quarterly reports), from Jan 1, 2023. All documents, including those we do not classify, are in the EDGAR filing index.
- Form 8-K · items 2.02, 9.01 · filed Nov 13, 2026 · filing · edition of Nov 13, 2026
- Form 10-Q · filed Nov 12, 2026 · filing · edition of Nov 12, 2026
- Form 8-K · items 2.02, 9.01 · filed Aug 7, 2026 · filing
- Form 10-Q · filed Aug 6, 2026 · filing
- Form 8-K · items 2.02, 9.01 · filed May 13, 2026 · filing
- Form 10-Q · filed May 12, 2026 · filing
- Form 8-K · items 5.02, 9.01 · filed Apr 24, 2026 · filing
- Form 8-K · items 2.02, 9.01 · filed Mar 13, 2026 · filing
- Form 10-K · filed Mar 12, 2026 · filing
- Form 8-K · items 2.02, 9.01 · filed Nov 13, 2025 · filing
- Form 10-Q · filed Nov 12, 2025 · filing
- Form 8-K · items 2.02, 9.01 · filed Aug 13, 2025 · filing
- Form 10-Q · filed Aug 12, 2025 · filing
- Form 8-K · items 2.02, 9.01 · filed May 14, 2025 · filing
- Form 10-Q · filed May 13, 2025 · filing
- Form 8-K · items 4.01, 9.01 · filed Apr 10, 2025 · filing
- Form 8-K · items 2.02, 9.01 · filed Mar 19, 2025 · filing
- Form 10-K · filed Mar 18, 2025 · filing
- Form 8-K · items 2.02, 9.01 · filed Nov 13, 2024 · filing
- Form 10-Q · filed Nov 12, 2024 · filing
- Form 8-K · items 5.02 · filed Oct 31, 2024 · filing
- Form 8-K · items 2.02, 9.01 · filed Aug 14, 2024 · filing
- Form 10-Q · filed Aug 13, 2024 · filing
- Form 25-NSE · filed Jul 18, 2024 · filing
- Form 8-K · items 5.02 · filed Jun 21, 2024 · filing
- Form 8-K · items 5.02, 7.01, 9.01 · filed May 22, 2024 · filing
- Form 8-K · items 2.02, 9.01 · filed May 10, 2024 · filing
- Form 10-Q · filed May 9, 2024 · filing
- Form 8-K · items 2.02, 9.01 · filed Mar 22, 2024 · filing
- Form 10-K · filed Mar 21, 2024 · filing
- Form 8-K · items 2.02, 9.01 · filed Nov 13, 2023 · filing
- Form 10-Q · filed Nov 9, 2023 · filing
- Form 8-K · items 2.02, 9.01 · filed Aug 11, 2023 · filing
- Form 10-Q · filed Aug 10, 2023 · filing
- Form SC 13D · filed Jun 15, 2023 · filing
- Form 10-Q · filed May 11, 2023 · filing
- Form 8-K · items 2.02, 9.01 · filed May 11, 2023 · filing
- Form 8-K · items 2.02, 9.01 · filed Mar 23, 2023 · filing
- Form 10-K · filed Mar 22, 2023 · filing